Evidence map›Paper›PMID 40083857›Full record

ReviewEngineering in life sciences2025

Magnetizing Biotech-Advances in (In Vivo) Magnetic Enzyme Immobilization.

Gizem Ölçücü, Karl-Erich Jaeger, Ulrich Krauss

Abstract readReview
In one paragraph

Review in Engineering in life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Effect of nanomaterials on cellulase enzyme produced by Aspergillus costaricensis and Trichoderma parareesei grown on rice husk.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gizem ÖlçücüInstitute of Bio- and Geosciences IBG-1: Biotechnology Forschungszentrum Jülich GmbH Jülich Germany.
Karl-Erich JaegerInstitute of Bio- and Geosciences IBG-1: Biotechnology Forschungszentrum Jülich GmbH Jülich Germany.
Ulrich KraussInstitute of Bio- and Geosciences IBG-1: Biotechnology Forschungszentrum Jülich GmbH Jülich Germany.ORCID https://orcid.org/0000-0003-2219-7388

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Industrial biocatalysis, a multibillion dollar industry, relies on the selectivity and efficacy of enzymes for efficient chemical transformations. However, enzymes, evolutionary adapted to mild biological conditions, often struggle in industrial processes that require harsh reaction conditions, resulting in reduced stability and activity. Enzyme immobilization, which addresses challenges such as enzyme reuse and stability, has therefore become a vital strategy for improving enzyme use in industrial applications. Traditional immobilization techniques rely on the confinement or display of enzymes within/on organic or inorganic supports, while recent advances in synthetic biology have led to the development of solely biological in vivo immobilization methods that streamline enzyme production and immobilization. These methods offer added benefits in terms of sustainability and cost efficiency. In addition, the development and use of multifunctional materials, such as magnetic (nano)materials for enzyme immobilization, has enabled improved separation and purification processes. The combination of both "worlds," opens up new avenues in both (industrial) biocatalysis, fundamental science, and biomedicine. Therefore, in this review, we provide an overview of established and recently emerging methods for the generation of magnetic protein immobilizates, placing a special focus on in vivo immobilization solutions.

Indexed as

biocatalysisin vivo enzyme immobilizationmagnetic nanoparticlesmagnetic protein aggregatesmagnetosomes

Identifiers

PMID40083857
PMCPMC11904115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.